The use of adjunctive therapy to alter the pathophysiology of bacterial meningitis

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The inflammation in the subarachnoid space (SAS) that develops in the course of bacterial meningitis may have a role in eradicating the infection, but also, ultimately, is the cause of the neurological sequelae associated with this infection. The presence of an inflammatory exudate in the SAS leads to alterations in the blood-brain barrier, altered cerebrospinal fluid dynamics, cerebral edema and increased intracranial pressure, and loss of cerebral autoregulation. Our increasing understanding of the pathophysiology of meningeal inflammation has led to therapeutic interventions to limit the degree of meningeal inflammation and neurologic sequelae. The inflammatory cascade that leads to alterations in central nervous system physiology will be reviewed as well as the experimental evidence and clinical trials demonstrating the efficacy of adjunctive therapy in reducing meningeal inflammation and decreasing the incidence and severity of neurological sequelae in bacterial meningitis.

Original languageEnglish (US)
Pages (from-to)138-147
Number of pages10
JournalClinical Neuropharmacology
Volume18
Issue number2
StatePublished - 1995

Fingerprint

Bacterial Meningitides
Inflammation
Subarachnoid Space
Nervous System Physiological Phenomena
Brain Edema
Intracranial Pressure
Exudates and Transudates
Hydrodynamics
Therapeutics
Infection
Blood-Brain Barrier
Nervous System
Cerebrospinal Fluid
Homeostasis
Central Nervous System
Clinical Trials
Incidence

Keywords

  • Adjunctive therapy
  • Bacterial meningitis
  • Inflammation

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

The use of adjunctive therapy to alter the pathophysiology of bacterial meningitis. / Roos, Karen.

In: Clinical Neuropharmacology, Vol. 18, No. 2, 1995, p. 138-147.

Research output: Contribution to journalArticle

@article{f7b7319a74244178a30bdccb45f770d0,
title = "The use of adjunctive therapy to alter the pathophysiology of bacterial meningitis",
abstract = "The inflammation in the subarachnoid space (SAS) that develops in the course of bacterial meningitis may have a role in eradicating the infection, but also, ultimately, is the cause of the neurological sequelae associated with this infection. The presence of an inflammatory exudate in the SAS leads to alterations in the blood-brain barrier, altered cerebrospinal fluid dynamics, cerebral edema and increased intracranial pressure, and loss of cerebral autoregulation. Our increasing understanding of the pathophysiology of meningeal inflammation has led to therapeutic interventions to limit the degree of meningeal inflammation and neurologic sequelae. The inflammatory cascade that leads to alterations in central nervous system physiology will be reviewed as well as the experimental evidence and clinical trials demonstrating the efficacy of adjunctive therapy in reducing meningeal inflammation and decreasing the incidence and severity of neurological sequelae in bacterial meningitis.",
keywords = "Adjunctive therapy, Bacterial meningitis, Inflammation",
author = "Karen Roos",
year = "1995",
language = "English (US)",
volume = "18",
pages = "138--147",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The use of adjunctive therapy to alter the pathophysiology of bacterial meningitis

AU - Roos, Karen

PY - 1995

Y1 - 1995

N2 - The inflammation in the subarachnoid space (SAS) that develops in the course of bacterial meningitis may have a role in eradicating the infection, but also, ultimately, is the cause of the neurological sequelae associated with this infection. The presence of an inflammatory exudate in the SAS leads to alterations in the blood-brain barrier, altered cerebrospinal fluid dynamics, cerebral edema and increased intracranial pressure, and loss of cerebral autoregulation. Our increasing understanding of the pathophysiology of meningeal inflammation has led to therapeutic interventions to limit the degree of meningeal inflammation and neurologic sequelae. The inflammatory cascade that leads to alterations in central nervous system physiology will be reviewed as well as the experimental evidence and clinical trials demonstrating the efficacy of adjunctive therapy in reducing meningeal inflammation and decreasing the incidence and severity of neurological sequelae in bacterial meningitis.

AB - The inflammation in the subarachnoid space (SAS) that develops in the course of bacterial meningitis may have a role in eradicating the infection, but also, ultimately, is the cause of the neurological sequelae associated with this infection. The presence of an inflammatory exudate in the SAS leads to alterations in the blood-brain barrier, altered cerebrospinal fluid dynamics, cerebral edema and increased intracranial pressure, and loss of cerebral autoregulation. Our increasing understanding of the pathophysiology of meningeal inflammation has led to therapeutic interventions to limit the degree of meningeal inflammation and neurologic sequelae. The inflammatory cascade that leads to alterations in central nervous system physiology will be reviewed as well as the experimental evidence and clinical trials demonstrating the efficacy of adjunctive therapy in reducing meningeal inflammation and decreasing the incidence and severity of neurological sequelae in bacterial meningitis.

KW - Adjunctive therapy

KW - Bacterial meningitis

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=0028953798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028953798&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 138

EP - 147

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 2

ER -